相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Leading RNA Interference Therapeutics Part 2: Silencing Delta-Aminolevulinic Acid Synthase 1, with a Focus on Givosiran
Pedro Renato de Paula Brandao et al.
MOLECULAR DIAGNOSIS & THERAPY (2020)
The biology, function, and biomedical applications of exosomes
Raghu Kalluri et al.
SCIENCE (2020)
Distinct Role of CD11b+Ly6G-Ly6C- Myeloid-Derived Cells on the Progression of the Primary Tumor and Therapy-Associated Recurrent Brain Tumor
Sheng-Yan Wu et al.
CELLS (2020)
Endocytosis of Extracellular Vesicles and Release of Their Cargo from Endosomes
Bhagyashree S. Joshi et al.
ACS NANO (2020)
Bintrafusp alfa, a bifunctional fusion protein targeting TGF-beta and PD-L1, in advanced squamous cell carcinoma of the head and neck: results from a phase I cohort
Byoung Chul Cho et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Local delivery of cardiac stem cells overexpressing HIF-1α promotes angiogenesis and muscular tissue repair in a hind limb ischemia model
Xing Pei et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Expression and clinical significance of LAG-3, FGL1, PD-L1 and CD8+T cells in hepatocellular carcinoma using multiplex quantitative analysis
Mengzhou Guo et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
LAG-3: from molecular functions to clinical applications
Takumi Maruhashi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
KEYNOTE-590: Phase III study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancer
Ken Kato et al.
FUTURE ONCOLOGY (2019)
Embryonic Stem Cells-Derived Exosomes Endowed with Targeting Properties as Chemotherapeutics Delivery Vehicles for Glioblastoma Therapy
Qingwei Zhu et al.
ADVANCED SCIENCE (2019)
Milk exosomes - Natural nanoparticles for siRNA delivery
Farrukh Aqil et al.
CANCER LETTERS (2019)
Safety of Nivolumab plus Low-Dose Ipilimumab in Previously Treated Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer
Michael A. Morse et al.
ONCOLOGIST (2019)
Combined Inhibition of TGF- Signaling and the PD-L1 Immune Checkpoint Is Differentially Effective in Tumor Models
Heng Sheng Sow et al.
CELLS (2019)
Combination of CTLA-4 and PD-1 blockers for treatment of cancer
Anand Rotte
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Plasma Fibrinogen-Like 1 as a Potential Biomarker for Radiation-Induced Liver Injury
Na-Kyung Han et al.
CELLS (2019)
Folate-displaying exosome mediated cytosolic delivery of siRNA avoiding endosome trapping
Zhen Zheng et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Aptamer-Functionalized Exosomes: Elucidating the Cellular Uptake Mechanism and the Potential for Cancer-Targeted Chemotherapy
Jianmei Zou et al.
ANALYTICAL CHEMISTRY (2019)
Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
Jun Wang et al.
CELL (2019)
Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression
Fengmei Pi et al.
NATURE NANOTECHNOLOGY (2018)
Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy
Tian Tian et al.
BIOMATERIALS (2018)
NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo
Gang Jia et al.
BIOMATERIALS (2018)
Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy
Junjie Wu et al.
CANCER LETTERS (2018)
Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors
Julius Strauss et al.
CLINICAL CANCER RESEARCH (2018)
Cellular uptake mechanism and comparative in vitro cytotoxicity studies of monomeric LMWP-siRNA conjugate
Junxiao Ye et al.
JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY (2018)
TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
Daniele V. F. Tauriello et al.
NATURE (2018)
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β
Yan Lan et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
In situ formed reactive oxygen species-responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy
Chao Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap
Wantong Song et al.
NATURE COMMUNICATIONS (2018)
Emerging strategies for combination checkpoint modulators in cancer immunotherapy
Aleksandra Popovic et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
被撤回的出版物: Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway (Retracted article. See vol. 15, pg. 10735, 2021)
Jianqin Lu et al.
ACS NANO (2018)
Immune-related adverse events of immune checkpoint inhibitors: a brief review
G. Myers
CURRENT ONCOLOGY (2018)
Exosomes: natural nanoparticles as bio shuttles for RNAi delivery
Saber Ghazizadeh Darband et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial
Frank Stephen Hodi et al.
LANCET ONCOLOGY (2018)
Exosomes as drug carriers for clinical application
Cuixia Di et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Cellular uptake of extracellular vesicles is mediated by clathrin-independent endocytosis and macropinocytosis
Helena Costa Verdera et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Checkpoint inhibitors in melanoma and early phase development in solid tumors: what's the future?
Paolo A. Ascierto et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
Sushrut Kamerkar et al.
NATURE (2017)
Migrating into the Tumor: a Roadmap for T Cells
Lieke L. van der Woude et al.
TRENDS IN CANCER (2017)
Adipose Tissue Macrophage-Derived Exosomal miRNAs Can Modulate In Vivo and In Vitro Insulin Sensitivity
Wei Ying et al.
CELL (2017)
Recent progress in development of siRNA delivery vehicles for cancer therapy
Hyun Jin Kim et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Considerations for the combination of anticancer vaccines and immune checkpoint inhibitors
Julius Strauss et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2016)
Effect of lentivirus-mediated integrin α V β 3-shRNA on tumor growth of mice with lung cancer xenografts
Tao Liang et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2016)
RGD Peptide Cell-Surface Display Enhances the Targeting and Therapeutic Efficacy of Attenuated Salmonella-mediated Cancer Therapy
Seung-Hwan Park et al.
THERANOSTICS (2016)
Harnessing the immune system to improve cancer therapy
Nikos E. Papaioannou et al.
ANNALS OF TRANSLATIONAL MEDICINE (2016)
Exosome Adherence and Internalization by Hepatic Stellate Cells Triggers Sphingosine 1-Phosphate-dependent Migration
Ruisi Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Exosomes as drug delivery vehicles for Parkinson's disease therapy
Matthew J. Haney et al.
JOURNAL OF CONTROLLED RELEASE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Molecular Magnetic Resonance Imaging of Angiogenesis In Vivo using Polyvalent Cyclic RGD-Iron Oxide Microparticle Conjugates
Stavros Melemenidis et al.
THERANOSTICS (2015)
Exosome Uptake through Clathrin-mediated Endocytosis and Macropinocytosis and Mediating miR-21 Delivery
Tian Tian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Exosomes for targeted siRNA delivery across biological barriers
Samir EL Andaloussi et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Exosomes Derived from Hypoxic Leukemia Cells Enhance Tube Formation in Endothelial Cells
Hiroko Tadokoro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells
Shin-ichiro Ohno et al.
MOLECULAR THERAPY (2013)
The roles of TGFβ in the tumour microenvironment
Michael Pickup et al.
NATURE REVIEWS CANCER (2013)
Recombinant human hepassocin stimulates proliferation of hepatocytes in vivo and improves survival in rats with fulminant hepatic failure
Chang-Yan Li et al.
GUT (2010)
Blockade of Programmed Death Ligand 1 Enhances the Therapeutic Efficacy of Combination Immunotherapy against Melanoma
Shari Pilon-Thomas et al.
JOURNAL OF IMMUNOLOGY (2010)
分享论文
